The current valuation score of Nkarta Inc is 7.62, ranking 222 out of 388 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.96, which is -73.24% below the recent high of -0.52 and -234.81% above the recent low of -6.55.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.